Chi Advisors LLC Akouos, Inc. Transaction History

Chi Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$2.6 - $5.16 $1.18 Million - $2.33 Million	452,238 Added 54.09%	1,288,358 $8.71 Million
Q4 2021 Feb 11, 2022	SELL	$7.65 - $11.38 $167,588 - $249,301	-21,907 Reduced 2.55%	836,120 $7.11 Million
Q1 2021 May 14, 2021	SELL	$13.87 - $21.04 $178,506 - $270,784	-12,870 Reduced 1.48%	858,027 $11.9 Million
Q4 2020 Feb 12, 2021	BUY	$17.03 - $22.45 $417,235 - $550,025	24,500 Added 2.89%	870,897 $17.3 Million
Q3 2020 Nov 12, 2020	SELL	$19.3 - $26.92 $2.48 Million - $3.46 Million	-128,588 Reduced 13.19%	846,397 $19.4 Million

Q2 2020 Aug 17, 2020	BUY	$22.0 - $22.5 $17.6 Million - $18 Million	799,985 Added 457.13%	974,985 $21.9 Million
Q2 2020 Aug 12, 2020	BUY	$22.0 - $22.5 $3.85 Million - $3.94 Million	175,000 New	175,000 $3.94 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Chi Advisors LLC with notifications on news.